This article summarizes and analyzes the salient topics on the diagnosis and management of endometrial polyps, focusing on the role of the hysteroscopy. Noninvasive investigations such as transvaginal ultrasonography, with or without the use of three-dimensional ultrasonography (3D US) and contrast techniques, remain the mainstay of first-line investigation. Hysteroscopic resection represents the gold standard minimally invasive treatment for endometrial polyps. It is the most effective management and allows histologic assessment, whereas blind biopsy or curettage have low diagnostic accuracy and should not be performed.
Highlights
- •
Office hysteroscopy with target-eyed biopsy is the gold standard for the diagnosis of endometrial polyps.
- •
Endometrial polyp’s removal has two main objectives: to resolve the symptomatology and to exclude neoplastic transformation.
- •
Outpatient and inpatient techniques are available for hysteroscopic polypectomy.
Introduction
Endometrial polyps are benign tumors within the endometrial mucosa consisting of a stromal axis surrounded by cylindrical epithelium containing variable quantities of glands and blood vessels. Although they may be found as an incidental finding, endometrial polyps are often associated with clinical symptoms such as abnormal vaginal bleeding and infertility .
Endometrial polyps can appear as a single or multiple growths, sessile or pedunculate, and of variable dimensions and color according to the degree of vascularization. The reported prevalence of endometrial polyps widely varies and ranges from 7.8% to 34.9%, depending upon the definition of a polyp, diagnostic method used, the population studied, and it appears to increase with age .
Classification
From the histological viewpoint, the following types of endometrial polyps can be distinguished:
- –
Hyperplastic polyps . Arising from the basal endometrial layer, which is sensitive to estrogen, they are the result of the estrogen stimulation not balanced by the effect of progestin. They can be associated with diffuse endometrial hyperplasia (EH) and can have fewer localized atypical areas, particularly in postmenopausal age.
- –
Atrophic polyps . Typical of postmenopausal age, they are generally regressive alterations of functional or hyperplastic polyps.
- –
Functional polyps . They show glandular alterations similar to those of the surrounding endometrium, as they respond to the hormonal stimuli of the menstrual cycle.
- –
Adenomyomatous polyps . They are characterized by varying amounts of smooth muscle cells and fibrous tissue. The “atypical” forms are characterized by the concomitant presence of benign endometrial glands and stroma with structural atypia consisting mainly of smooth muscle, and in which the likelihood of association with endometrial cancer transformation is about 9%.
- –
Pseudopolyps . Small sessile lesions whose structure is identical to the surrounding endometrium; they are detected only in the secretory phase of the menstrual cycle, and then disappear with the menstrual flow.
Classification
From the histological viewpoint, the following types of endometrial polyps can be distinguished:
- –
Hyperplastic polyps . Arising from the basal endometrial layer, which is sensitive to estrogen, they are the result of the estrogen stimulation not balanced by the effect of progestin. They can be associated with diffuse endometrial hyperplasia (EH) and can have fewer localized atypical areas, particularly in postmenopausal age.
- –
Atrophic polyps . Typical of postmenopausal age, they are generally regressive alterations of functional or hyperplastic polyps.
- –
Functional polyps . They show glandular alterations similar to those of the surrounding endometrium, as they respond to the hormonal stimuli of the menstrual cycle.
- –
Adenomyomatous polyps . They are characterized by varying amounts of smooth muscle cells and fibrous tissue. The “atypical” forms are characterized by the concomitant presence of benign endometrial glands and stroma with structural atypia consisting mainly of smooth muscle, and in which the likelihood of association with endometrial cancer transformation is about 9%.
- –
Pseudopolyps . Small sessile lesions whose structure is identical to the surrounding endometrium; they are detected only in the secretory phase of the menstrual cycle, and then disappear with the menstrual flow.
Etiopathogenesis
The exact cause of polyps is unknown, probably due to many causative factors. Numerous hypotheses for the onset of endometrial polyps have been suggested and they include the following:
- –
Genetic and familial hereditary factors : clusters of anomalies in chromosomes 6 and 12 that may alter the proliferative process, resulting in endometrial overgrowth and polyp formation . Indeed, familial adenomatous polyposis, diabetes, and hypertension may have a role.
- –
Inflammatory factors : women with polyps demonstrate alterations in endometrial levels of matrix metalloproteinases and cytokines compared with control subjects; these changes could produce the pathologic processes or they could be the result of the pathology development .
- –
Endocrine factors : main example is a condition of imbalanced hyperestrogenism (obesity, polycystic ovary syndrome, late menopause, estrogen secreting gonadal stromal tumors, and chronic liver disease) .
- –
Iatrogenic factors : as unbalanced estrogen therapy (toremifene or tamoxifen therapy for breast cancer).
Clinical appearance
Although endometrial polyps may be totally asymptomatic, frequently, they are found to be associated with one or many symptoms, as follows:
- 1.
Abnormal Uterine Bleeding (AUB) : It is the most common presenting symptom for endometrial polyp both premenopausal and postmenopausal age, occurring in approximately 68% of cases . However, it may present as intermenstrual spotting and/or postcoital spotting (particularly in cases of coexisting cervical polyps).
The presence of endometrial polyps in a significant proportion of patients with AUB is because of the patient’s hyperestrogenic state at the onset of symptoms, and is not itself a direct cause of these symptoms. Instead, endometrial polyps may directly account for bleeding, particularly where their mass and/or number occupy much of the volume of the uterine cavity, causing an ulceration of the endometrium.
In postmenopausal patients, AUB can be highly variable related to the number, size, and vascularity of the lesions, and is usually associated with an increased risk of malignancy in a polypoid lesion.
- 2.
Infertility : Endometrial polyps are found in 15–25% of infertile women, although the causal relationship remains uncertain . There are underlying etiological patterns that might have an adverse impact on female fertility, and most of them are still being studied. Hypotheses include mechanical obstruction hindering ostium function and affecting sperm migration and biochemical effects of polyps on implantation or embryo development . Women treated with gonadotropins for infertility are exposed to a higher level of estrogens, which predispose them to the development of endometrial polyps . Numerous studies have shown an increased pregnancy rate secondary to a polypectomy (15–24%). However, the lack of randomized trials does not allow for a definitive conclusion on the potential role of polypectomies in increasing pregnancy rates.
- 3.
Rare symptoms : Pain of variable intensity, related to reflex contractions of the uterus, can rarely occur; the contractions can displace the lesion progressively toward the cervix and can cause, in some instances, its complete expulsion. Large polyps can also present with necrosis, which can result in a vaginal serosanguinous discharge having an unpleasant odor.
Malignant transformation
Most endometrial polyps are benign; however, they may become hyperplastic, with malignant transformation developing in 0–12.9% of polyps in case series reported to date . The risk of malignancy associated with endometrial polyps is highest in postmenopausal symptomatic women. The reported incidence of carcinoma confined to endometrial polyps varies from 0% to 4.8%. The risk of malignancy in premenopausal women has been significantly correlated with increasing age and menopausal status, polyps with a size >1.5 cm, hypertension, and tamoxifen use . Ultrasonography may aid in the diagnosis of neoplastic change within endometrial polyps: the variation in range is dependent on the endometrial thickness used as the requirement for further investigation by more invasive methods .
Diagnosis
Transvaginal sonography
An endometrial polyp appears in two-thirds of cases with a focal, hyperechoic, and well-defined thickening of the endometrium, at times associated with multiple areas of hypoechogenicity. Occasionally, the polyp may appear delineated by a thin hypoechoic stripe.
The polyp may also appear as a no-specific endometrial thickening or focal mass within the endometrial cavity: such sonographic findings are not specific to polyps, and other endometrial abnormalities such as submucosal fibroids may have the same features ( Fig. 1 ).
Transvaginal sonography (TVS) is best performed in premenopausal women before 10th day of the cycle, when the endometrium is at its thinnest, to minimize the risk of false-positive and false-negative findings . Indeed, Doppler fluximetry, especially at childbearing age, is often capable of identifying the vascular axis of the polyp. Finally, 3D US is an innovative imaging technique with the ability to generate multiplanar reconstructed images through the uterus and its external contours. The coronal view is the most useful scan plan, allowing more accurate visualization between the endometrium and myometrium at the fundus and cornual angles ( Fig. 2 ).
Sonohysterography
The saline infusion sonography or sonohysterography (SHG) increases sonographic contrast of the endometrial cavity, enabling delineation of the size, location, and other features of an endometrial polyp. Polyp appears as an echogenic intracavitary mass with either broad base or thin stalk outlined by fluid . This technique improves diagnostic accuracy, allowing resection of the polyp’s pedicle from the uterine walls, a proper measurement of its size, and a more accurate localization .
Hysteroscopy
Hysteroscopy with guided biopsy is the gold standard for the diagnosis of endometrial polyps . It does not only allow for immediate diagnostic confirmation, but also provides additional clinical information required to define the proper therapeutic approach. The endoscopic examination of endometrial polyps should include an evaluation of the following parameters:
- –
Number.
- –
Size : Considering that the maximum spread of the jaws of a 5-French (Fr) alligator forceps is 6 mm, positioning the opened jaws close to the lesion it allows to obtain a more or less correct estimate of its dimensions ( Fig. 3 ).
- –
Location and relationship to the tubal ostia.
- –
Texture : Generally, polyps are soft, but some forms can be hard and semi-myomatous (adenomyomatous polyp).
- –
Characteristics of the implantation base : sessile or pedunculated.
- –
Coating mucosa . The specific features of a polyp’s endometrial lining are crucial for distinguishing functional polyps – characterized by their similarity to the adjacent endometrium – from hyperplastic ones. An irregular surface, with areas of inflammation and/or necrosis, or coexisting glandular cystic neoplasms are highly suggestive of EH associated with polyps. In order to make a differential diagnosis, in such cases, careful scrutiny is required to evaluate the possible concomitant presence of glandular architectural abnormalities often found with polyps that are highly suggestive of EH ( Fig. 4 ).